News Daily News Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care Shelley Wood May 27, 2021
News Conference News ACC 2021 Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF Michael O'Riordan May 25, 2021
News Industry News Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device May 25, 2021
News Conference News EuroPCR 2021 CLASP 2-Year Data Promising for Pascal Transcatheter Mitral Repair Shelley Wood May 19, 2021
News Conference News EuroPCR 2021 Subcutaneous GP IIb/IIIa Inhibitor in STEMI Is Fast, Potent in Early Study Todd Neale May 18, 2021
News Conference News ACC 2021 Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs Todd Neale May 18, 2021
News Conference News ACC 2021 ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19 Todd Neale May 17, 2021
News Conference News ACC 2021 COVID-19 Doubled Burnout Rates in Cardiology Yael L. Maxwell May 17, 2021
News Conference News ACC 2021 Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF Yael L. Maxwell May 16, 2021
News Conference News ACC 2021 PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI L.A. McKeown May 15, 2021
News Industry News Essentials of Clinical Trial Design: Statistics 101 for the Budding Interventionalist May 13, 2021
News Daily News Surgery After Failed Mitral Edge-to-Edge Repair Tends to Be Replacement Todd Neale May 05, 2021
News Conference News SCAI 2021 Harmony TPV Continues to Reduce Pulmonary Valve Regurgitation at 1 Year Yael L. Maxwell May 04, 2021
News Conference News SCAI 2021 Cardiogenic Shock: Protocols, Clear Definitions Advance the Field Caitlin E. Cox April 30, 2021
News Daily News Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials L.A. McKeown April 26, 2021
News Daily News Differentiating Type 1 and Type 2 MI Still ‘Both Art and Science’ Todd Neale April 23, 2021